PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Methotrexate
Presentation Product Chemical substance Chapter Items dispensed
Ebetrex 25mg/1.25ml inj pre-filled syringes
1001030U0BFADBP
Ebetrex (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Ebetrex 30mg/1.5ml inj pre-filled syringes
1001030U0BFAFBR
Ebetrex (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Ebetrex 7.5mg/0.75ml inj pre-filled syringes
1001030U0BFAAAZ
Ebetrex (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Jylamvo 2mg/ml oral solution
1001030U0BHAACF
Jylamvo Methotrexate Musculoskeletal and Joint Diseases No data available
Methofill 27.5mg/0.55ml inj pre-filled injector
1001030U0BGAIBZ
Methofill (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methofill 27.5mg/0.55ml inj pre-filled syringes
1001030U0BGASBN
Methofill (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 10mg/1ml inj pre-filled syringes
1001030U0AABBBB
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 12mg/5ml oral liquid
1001030U0AAASAS
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 15mg/1.5ml inj pre-filled syringes
1001030U0AABCBC
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 15mg/5ml oral liquid
1001030U0AAARAR
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 17.5mg/5ml oral liquid
1001030U0AAATAT
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 18mg/5ml oral liquid
1001030U0AAAXAX
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 1g/40ml solution for injection vials
0801030P0AACTCT
Methotrexate Methotrexate Malignant Disease and Immunosuppression No data available
Methotrexate 1mg/5ml oral liquid
1001030U0AAALAL
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 200mg/8ml solution for injection vials
0801030P0AAASAS
Methotrexate Methotrexate Malignant Disease and Immunosuppression No data available
Methotrexate 20mg/1ml inj pre-filled syringes
1001030U0AABSBS
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 20mg/5ml oral liquid
1001030U0AAAVAV
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 22.5mg/5ml oral liquid
1001030U0AAAYAY
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 25mg/1.25ml inj pre-filled syringes
1001030U0AABPBP
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 25mg/2.5ml inj pre-filled syringes
1001030U0AABDBD
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 25mg/3ml inj pre-filled syringes
0801030P0AAFDFD
Methotrexate Methotrexate Malignant Disease and Immunosuppression No data available
Methotrexate 25mg/5ml oral liquid
1001030U0AAAAAA
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 27.5mg/0.55ml inj pre-filled syringes
1001030U0AABNBN
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available
Methotrexate 27.5mg/1.1ml inj pre-filled syringes
0801030P0AADRDR
Methotrexate Methotrexate Malignant Disease and Immunosuppression No data available
Methotrexate 3.75mg/5ml oral liquid
1001030U0AAAJAJ
Methotrexate (Rheumatism) Methotrexate Musculoskeletal and Joint Diseases No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.